De Pascale, Gennaro
 Distribuzione geografica
Continente #
EU - Europa 3.501
NA - Nord America 3.202
AS - Asia 721
SA - Sud America 45
AF - Africa 20
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 6
Totale 7.512
Nazione #
US - Stati Uniti d'America 3.178
DE - Germania 1.054
SE - Svezia 665
IT - Italia 564
CN - Cina 435
PL - Polonia 245
UA - Ucraina 222
IE - Irlanda 216
FR - Francia 191
GB - Regno Unito 127
TR - Turchia 99
FI - Finlandia 77
IN - India 71
BE - Belgio 26
HK - Hong Kong 24
IR - Iran 22
AU - Australia 16
CA - Canada 16
ES - Italia 15
SG - Singapore 15
CH - Svizzera 14
CO - Colombia 13
JP - Giappone 13
NL - Olanda 13
BR - Brasile 12
RU - Federazione Russa 12
KR - Corea 10
AR - Argentina 8
CI - Costa d'Avorio 7
GR - Grecia 7
MX - Messico 7
VN - Vietnam 7
AT - Austria 6
CL - Cile 6
EG - Egitto 6
EU - Europa 6
MK - Macedonia 6
RO - Romania 6
BG - Bulgaria 5
EE - Estonia 5
TW - Taiwan 5
VA - Santa Sede (Città del Vaticano) 5
CZ - Repubblica Ceca 4
PE - Perù 4
PH - Filippine 4
RS - Serbia 4
IL - Israele 3
NO - Norvegia 3
PT - Portogallo 3
AF - Afghanistan, Repubblica islamica di 2
KZ - Kazakistan 2
MU - Mauritius 2
NG - Nigeria 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BD - Bangladesh 1
CM - Camerun 1
DZ - Algeria 1
ET - Etiopia 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
ID - Indonesia 1
IQ - Iraq 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MY - Malesia 1
NZ - Nuova Zelanda 1
TH - Thailandia 1
Totale 7.512
Città #
Chandler 691
Ashburn 240
Dublin 215
Warsaw 210
Jacksonville 153
Ann Arbor 140
Nanjing 126
San Mateo 125
New York 115
Milan 93
Wilmington 88
Dearborn 82
Fairfield 82
Nürnberg 80
Woodbridge 80
Chicago 75
Rome 66
Seattle 66
Boston 63
Marseille 63
Izmir 62
Houston 61
Cattolica 54
Beijing 50
Redwood City 49
Nanchang 48
Princeton 45
Lawrence 39
Munich 31
Helsinki 30
Kraków 30
Bremen 29
Kunming 28
Cambridge 27
Redmond 23
Hangzhou 22
Brussels 21
Norwalk 20
Augusta 19
Pune 19
Hebei 18
Lancaster 18
Mountain View 18
Tianjin 18
Kocaeli 17
Padova 16
London 15
Shenyang 15
University Park 15
Hong Kong 14
Los Angeles 14
Boardman 13
Guangzhou 13
Jiaxing 13
Washington 13
Changsha 12
Kish 12
San Diego 12
Verona 12
Falls Church 11
Leawood 11
Turin 10
Zhengzhou 10
Hefei 8
Zurich 8
Abidjan 7
Andover 7
Busto Arsizio 7
Fremont 7
Renton 7
Shanghai 7
Brooklyn 6
Buenos Aires 6
Detroit 6
Jinan 6
Lanzhou 6
Ottawa 6
Seoul 6
Shawnee 6
Clusone 5
Dong Ket 5
Edinburgh 5
Ferrara 5
Istanbul 5
Monmouth Junction 5
Paris 5
Philadelphia 5
Santiago 5
Simi Valley 5
Sofia 5
Torino 5
Vienna 5
Arzano 4
Baotou 4
Belgrade 4
Bern 4
Buffalo 4
Cairo 4
Changchun 4
Gevgelija 4
Totale 4.083
Nome #
Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients 305
(1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: An observational study 226
Combined use of serum (1,3)-β-D-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units 209
Colistin use in critically ill patients: in search of the optimal dosing. 204
Hospital-Acquired Infections in Critically Ill Patients With COVID-19 190
Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index 169
(1,3)-β-d-Glucan-based empirical antifungal interruption in suspected invasive candidiasis: A randomized trial 157
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy. 153
Validation of a new HPLC-UV method for determination of the antibiotic linezolid in human plasma and in bronchoalveolar lavage 148
Diagnosis of invasive aspergillosis by a commercial real-time PCR assay for Aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients compared to a galactomannan enzyme immunoassay 146
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy 133
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy. 131
Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index 127
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 127
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 122
Neurological involvement during legionellosis, look beyond the lung 115
Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration 115
Data on the application of early coagulation support protocol in the management of major trauma patients 110
High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria 108
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy 107
The importance of airway and lung microbiome in the critically ill 107
Epidemiology of intra-abdominal infection and sepsis in critically ill patients: "AbSeS", a multinational observational cohort study and ESICM Trials Group Project 104
Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index 97
Neurological involvement during Legionellosis, look beyond the lung 97
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 97
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality. 95
Prediction models to identify hospitalized patients at risk of being colonized or infected with multidrug-resistant Acinetobacter baumannii calcoaceticus complex. 95
A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality 95
Why Should We Monitor (1-3)- -D-Glucan Levels during Invasive Candidiasis? Just Ask Your Ophthalmologist! 90
Acute myopathic quadriplegia in COVID-19 patients in the intensive care unit 87
Comparative performance evaluation of Wako β-glucan test and Fungitell assay for the diagnosis of invasive fungal diseases 86
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality 83
Noninvasive ventilation for the immunocompromised patient: always appropriate? 83
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 83
Weaning from mechanical ventilation in intensive care units across 50 countries (WEAN SAFE): a multicentre, prospective, observational cohort study 80
Efficacy of Ceftazidime-avibactam Salvage Therapy in Patients with Infections Caused by KPC-producing Klebsiella pneumoniae 80
Severe pneumonia in intensive care: cause, diagnosis, treatment and management: a review of the literature 77
Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients 77
Aerosolized colistin cost-effectiveness. Response 77
Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration 76
Severe pneumonia in intensive care: cause, diagnosis, treatment and management: a review of the literature 72
A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality 72
Lice, rodents, and many hopes: a rare disease in a young refugee 71
Risk factors for mortality and cost implications of complicated intra-abdominal infections in critically ill patients 71
Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections 70
Successful treatment of multidrug-resistant Acinetobacter baumannii ventriculitis with intrathecal and intravenous colistin 68
Early nasal high-flow versus Venturi mask oxygen therapy after lung resection: A randomized trial 68
Sarilumab use in severe SARS-CoV-2 pneumonia 68
Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia 67
Staphylococcus aureus ventilator-associated pneumonia in patients with COVID-19: clinical features and potential inference with lung dysbiosis 67
Why should we monitor (1-3)-β-D-glucan levels during invasive candidiasis? Just ask your ophthalmologist! 66
Severe pneumonia in intensive care: cause, diagnosis, treatment and management: a review of the literature 65
Dose of colistin: a work in progress? 65
The challenge of identifying resistant-organism pneumonia in the emergency department: still navigating on the erie canal? 63
High Failure Rate of Noninvasive Oxygenation Strategies in Critically Ill Subjects With Acute Hypoxemic Respiratory Failure Due to COVID-19 63
Appropriate Tigecycline Use for Extensively Drug-Resistant Infections: The Standard Dose May Not Be Enough! 62
Response 61
Fungal infections in the ICU: advances in treatment and diagnosis 61
The place of dexmedetomidine light sedation in patients with acute brain injury 61
CO2driven endotracheal tube cuff control in critically ill patients: A randomized controlled study 60
Why should we monitor (1-3)-β-D-glucan levels during invasive candidiasis? Just ask your ophthalmologist! 59
Effect of Helmet Noninvasive Ventilation vs High-Flow Nasal Oxygen on Days Free of Respiratory Support in Patients With COVID-19 and Moderate to Severe Hypoxemic Respiratory Failure: The HENIVOT Randomized Clinical Trial 56
Transfusion practice in patients receiving VV ECMO (PROTECMO): a prospective, multicentre, observational study 52
Microbiologic surveillance through subglottic secretion cultures during invasive mechanical ventilation: a prospective observational study 51
Comparable Serum and Plasma 1,3-β-D-Glucan Values Using the Wako β-Glucan Test Assay in Patients with Probable or Proven Fungal Diseases 50
Double carbapenem as a rescue strategy for the treatment of severe carbapenemase-producing Klebsiella pneumoniae infections: A two-center, matched case-control study 50
Effects of thyroid hormone treatment on diaphragmatic efficiency in mechanically ventilated subjects with nonthyroidal illness syndrome 50
Diagnosis and Treatment of Bacterial Pneumonia in Critically Ill Patients with COVID-19 Using a Multiplex PCR Assay: A Large Italian Hospital’s Five-Month Experience 50
Predictors of choice of initial antifungal treatment in intraabdominal candidiasis 48
Early coagulation support protocol: A valid approach in real-life management of major trauma patients. Results from two Italian centres 47
Hemadsorption 46
Protective effect of SARS-CoV-2 preventive measures against ESKAPE and Escherichia coli infections 46
Double carbapenem as a rescue strategy for the treatment of severe carbapenemase-producing Klebsiella pneumoniae infections: a two-center, matched case-control study 45
Early nasal high-flow versus Venturi mask oxygen therapy after lung resection: a randomized trial 45
Miliary tuberculosis leading to acute respiratory distress syndrome: Clinical experience in pediatric intensive care 43
Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study 43
Usefulness of differential time to positivity between catheter and peripheral blood cultures for diagnosing catheter-related bloodstream infection: Data analysis from routine clinical practice in the intensive care unit 41
Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure: the DIANA study 40
Noninvasive ventilation and high-flow oxygen therapy for severe community-acquired pneumonia 39
Tigecycline pharmacokinetics in critically ill patients on renal replacement therapy: possible warnings and potential perspectives for the research agenda 38
How to manage aspergillosis in non-neutropenic intensive care unit patients 37
Risk factors for acute kidney injury in critically ill patients receiving high intravenous doses of colistin methanesulfonate and/or other nephrotoxic antibiotics: a retrospective cohort study 37
Desirability of outcome ranking (DOOR) for comparing diagnostic tools and early therapeutic choices in patients with suspected candidemia 36
Lung Recruitability and Positive End-Expiratory Pressure Setting in ARDS Caused by COVID-19 36
Clinical and organizational factors associated with mortality during the peak of first COVID-19 wave: the global UNITE-COVID study 35
Remdesivir plus Dexamethasone in COVID-19: A cohort study of severe patients requiring high flow oxygen therapy or non-invasive ventilation 35
Incidence of bloodstream infections due to multidrug-resistant pathogens in ordinary wards and intensive care units before and during the COVID-19 pandemic: a real-life, retrospective observational study 35
null 34
Lung ultrasound predicts non-invasive ventilation outcome in COVID-19 acute respiratory failure: A pilot study 27
T2Bacteria magnetic resonance assay for the rapid detection of ESKAPEc pathogens directly in whole blood 26
Compassionate use of anti-IL6 receptor antibodies in critically ill patients with acute respiratory distress syndrome due to SARS-CoV-2 22
Long-term outcome of COVID-19 patients treated with helmet noninvasive ventilation vs. high-flow nasal oxygen: a randomized trial 20
Antimicrobial Exposure in Critically Ill Patients with Sepsis-Associated Multi-Organ Dysfunction Requiring Extracorporeal Organ Support: A Narrative Review 19
Cefiderocol for severe carbapenem-resistant a. Baumannii pneumonia: Towards the comprehension of its place in therapy 18
Myocardial Injury Portends a Higher Risk of Mortality and Long-Term Cardiovascular Sequelae after Hospital Discharge in COVID-19 Survivors 17
Use of an innovative cuff pressure control and subglottic secretions drainage system in COVID-19 ARDS patients undergoing pronation 15
Effect of Cholecalciferol Supplementation on Vitamin D Status and Cathelicidin Levels in Sepsis: A Randomized, Placebo-Controlled Trial 14
Bloodstream infections caused by extended-spectrum-β-lactamase- producing Escherichia coli: Risk factors for inadequate initial antimicrobial therapy 13
Lung ultrasound predicts non-invasive ventilation outcome in COVID-19 acute respiratory failure: a pilot study 12
Use of High-Dose Nebulized Colistimethate in Patients with Colistin-Only Susceptible Acinetobacter baumannii VAP: Clinical, Pharmacokinetic and Microbiome Features 11
Totale 7.627
Categoria #
all - tutte 26.195
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.195


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019214 0 0 0 0 0 0 0 0 0 59 104 51
2019/20201.050 168 90 83 69 88 110 102 42 78 59 95 66
2020/2021794 37 68 23 54 81 64 103 31 96 54 133 50
2021/20221.086 90 73 67 68 84 57 24 157 59 71 163 173
2022/20232.103 227 261 133 282 142 231 105 199 244 107 108 64
2023/2024982 76 273 63 58 67 193 96 93 39 24 0 0
Totale 7.647